Citius Oncology, Inc. (CTOR)
NASDAQ: CTOR · Real-Time Price · USD
1.370
+0.110 (8.73%)
At close: Nov 28, 2025, 4:00 PM EST
1.430
+0.060 (4.38%)
Pre-market: Dec 1, 2025, 7:00 AM EST
Citius Oncology Market Cap
Citius Oncology has a market cap or net worth of $114.41 million as of December 1, 2025. Its market cap has increased by 22.49% in one year.
Market Cap
114.41M
Enterprise Value
118.21M
1-Year Change
22.49%
Ranking
Category
Stock Price
$1.37
Market Cap Chart
Since December 8, 2022, Citius Oncology's market cap has increased from $90.21M to $114.41M, an increase of 26.82%. That is a compound annual growth rate of 8.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 114.41M | 39.04% |
| Dec 31, 2024 | 82.29M | -15.88% |
| Dec 29, 2023 | 97.81M | 7.68% |
| Dec 30, 2022 | 90.84M | 0.69% |
| Dec 8, 2022 | 90.21M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 962.96B |
| Johnson & Johnson | 498.53B |
| AbbVie | 402.43B |
| UnitedHealth Group | 298.72B |
| AstraZeneca | 286.85B |
| Merck & Co. | 260.19B |
| Novartis AG | 249.40B |
| Abbott Laboratories | 224.14B |